Beyond Inflammation: Chronic Rheumatic Pain as a Stable Pathological Functional System

The contemporary discussion of chronic rheumatic pain has begun to move beyond a narrow inflammatory model. Recent reporting from EULAR 2026 emphasized that a substantial proportion of patients continue to experience severe or unacceptable pain years after diagnosis, even in the context of anti-inflammatory treatment, and proposed several important contributors to this persistent burden, including nociplastic pain, poor sleep, psychological distress, and kinesiophobia. This shift is important because it recognizes that pain persistence cannot always be explained by active inflammation alone. 

Yet the findings may support an even deeper interpretation. Rather than viewing these variables as separate complicating factors layered onto inflammatory disease, it may be more accurate to understand them as elements of a unified pathological organization. In this view, chronic rheumatic pain can evolve into a relatively stable pathological functional system, one in which altered nociceptive processing, sleep disruption, emotional distress, and fear-based behavior become linked in self-reinforcing loops that sustain pain even after inflammatory control has improved. From findings to mechanism

The explanation presented in the current rheumatology discussion is already more sophisticated than the traditional assumption that pain is simply proportional to synovitis or tissue inflammation. In rheumatoid arthritis and related conditions, persistent pain may remain even when standard disease markers suggest therapeutic success, and centrally mediated pain features may predict long-term pain outcomes more strongly than baseline inflammatory markers. Sleep disturbance has also been shown to predict subsequent pain, with evidence suggesting that one pathway may involve dysregulated pain processing and enhanced pain sensitization. 

These findings invite a broader mechanistic interpretation. If poor sleep increases pain sensitivity, if pain heightens vigilance and emotional strain, if distress promotes fear of movement, and if movement avoidance contributes to deconditioning and worsening pain experience, then the clinical picture is no longer adequately described as a set of coexisting symptoms. It begins to resemble a functionally integrated pathological state. What persists is not merely inflammation plus secondary distress, but an organized syndrome sustained by reciprocal biological, psychological, and behavioral reinforcement. 

The pathological functional system

The concept of a stable pathological functional system provides a useful way to organize this problem. Such a system emerges when initially adaptive or reactive processes become locked into a pattern that reproduces suffering. In chronic rheumatic pain, the original inflammatory disease may act as the trigger, but over time the persistence of pain may depend increasingly on central sensitization, sleep fragmentation, learned avoidance, and maladaptive interpretation of bodily signals rather than on peripheral inflammation alone. 

This does not mean that inflammation becomes irrelevant. Rather, it means that inflammation may cease to be the sole or dominant mechanism maintaining the patient’s pain. That distinction is clinically crucial. It explains why further escalation of anti-inflammatory therapy may produce diminishing returns in some patients, while interventions targeting sleep, pain processing, fear, and behavior may yield meaningful benefit even when inflammatory management has already been optimized. 

Why this view is positive

This way of thinking is positive because it makes a frustrating problem more intelligible and more treatable. Under a purely inflammatory model, persistent pain after inflammatory control can appear puzzling, discouraging, or even suggestive of therapeutic failure. Under the functional-systems model, that same persistence becomes understandable as the output of a structured but modifiable network. The patient is no longer viewed as having symptoms that are disproportionate or inexplicable, but as expressing a chronic pain state with its own internal logic. 

That conceptual shift expands the therapeutic field. A system can be interrupted at multiple points: sleep can be improved, fear of movement can be reduced, safe and graded activity can be restored, and central pain amplification can be identified and addressed more directly. The model is therefore hopeful because it replaces clinical frustration with strategic intervention. It suggests that even when pain cannot be eliminated immediately, the mechanisms that perpetuate it can still be weakened. 

Clinical significance

The practical implication is that persistent rheumatic pain should be phenotyped rather than simply reclassified as residual disease activity. When pain persists despite reasonable inflammatory control, clinicians should consider whether they are observing the consequences of an established pathological functional system rather than an isolated pharmacologic shortfall. This encourages a more precise and humane approach to management, one that integrates rheumatology with sleep medicine, pain science, rehabilitation, and behavioral care. 

Seen in this light, the findings presented in the current discussion do more than identify hidden drivers of chronic pain. They point toward a new mechanism of chronicity. Persistent rheumatic pain may be maintained by the formation of a stable pathological functional system, and this recognition is clinically valuable because what is functionally organized can also be therapeutically reorganized. 

Mykola Iabluchanskyi together with Andriy Yabluchanskiy